CONCORDANCE TABLE Section(s) of the Registration Document • Reference to a corporate governance code or, failing this, justification and indication of the rulesSection 16.4.1 adopted in addition to the legal requirements • Specific terms and conditions of shareholder participation in the general meeting or provisions Section 21.2.5 of the statutes providing for such terms and conditions 7. 3. Information related to the items having a potential impact in the event of public offerings: i. Capital structure of the Company; Section 21.1.8.1 ii. Restrictions under the articles of association on the exercise of voting rights or the transfer N/A of shares disclosed in accordance with article L.223-11 of the French Commercial Code; iii. Direct or indirect holdings in the share capital of the Company of which it is informed underSection 18.1.2 articles L.233-7 and L.233-12 of the French Commercial Code; iv. Holders of any securities conferring special rights of control and descriptions thereof; Sections 18.2 – 18.3 v. Control mechanisms provided for in a potential employee stock ownership system where N/A control rights are not exercised by the latter; vi. Shareholders’ agreements known to the Company and which may result in share transferSection 18.2 and voting rights restrictions; vii. Rules and regulations pertaining to the appointment and replacement of members of Section 21.2.2 the Board of Directors and modifications to the bylaws of the Company; viii.Powers of the Board of Directors for the issuance and buybacks of shares; Sections 21.1.3 and 21.1.6 ix. Agreements concluded by the Company that may be modified or terminated in the event N/A of a change in control of the Company, except if such disclosure, excluding the case where legally required, materially adversely affect its interest; x. Agreements providing for severance payments for members of the Board of Directors Section 19.2.2 or employees in the event of resignation, dismissal without just and sufficient cause or termination of employment resulting from a public offering. The report on Corporate Governance and the information This Registration Document includes the resolutions that have required under this report were prepared and elaborated by the been published in the French Bulletin des Annonces Légales Board of Directors pursuant to article L.225-37 of the French Obligatoires in accordance with applicable legislation and Commercial Code, with the involvement of the executive and submitted to the shareholders’ meeting cal led to approve the management committees. consolidated financial statements for the fiscal year ended The report was adopted by the Board of Directors held on December 31, 2017 which have been held on April 12, 2018. February 27, 2018, upon recommendation of the audit committee, which met on February 26, 2018, and was sent to the statutory auditors. 4 – GENSIGHT BIOLOGICS – 2017 Registration Document